Shareholders' Equity and Capital Stock - Schedule of outstanding RSUs (Details) - USD ($) $ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Shareholders Equity and Capital Stock | ||
| Number of RSUs | 1,097,929 | 1,127,706 |
| Weighted-Average Remaining contractual life (years) | 1 year | |
| Aggregate Fair Value | $ 1,493,184 | |
| 2026-12-12 | ||
| Shareholders Equity and Capital Stock | ||
| Number of RSUs | 464,782 | |
| Weighted-Average Remaining contractual life (years) | 6 months | |
| Aggregate Fair Value | $ 632,104 | |
| Vesting Date | Dec. 12, 2026 | |
| 2027-12-22 | ||
| Shareholders Equity and Capital Stock | ||
| Number of RSUs | 633,147 | |
| Weighted-Average Remaining contractual life (years) | 1 year 6 months | |
| Aggregate Fair Value | $ 861,080 | |
| Vesting Date | Dec. 22, 2027 |
| X | ||||||||||
- Definition Aggregate fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Date when the awards are vested under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|